Duration and magnitude of hypotension and monocyte deactivation in patients with community-acquired pneumonia

Shock

Volumn 36, Issue 6, 2011, Pages 553-559

  Simon, Peter M ^a   Delude, Russell L ^a,b   Lee, Minjae ^a,c   Kong, Lan ^a,c   Guzik, Lynda J ^a   Huang, David T ^a,d   Angus, Derek C ^a   Kellum, John A ^a  

^a Clinical Research Investigation   (United States)

^b UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS   (United States)

^c GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

cytokine; flow cytometry; HLA DR; hypotension; immune suppression; monocyte deactivation; Septic shock; SOFA

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; COMMUNITY ACQUIRED PNEUMONIA; CYTOKINE RELEASE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; MONOCYTES; PNEUMONIA; SHOCK, SEPTIC;

EID: 81755174121     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318235331e     Document Type: Article

References (35)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29(7):1303-1310, 2001. (Pubitemid 32641789)
2. Cavaillon J-M, Adrie C, Fitting C, Adib-Conquy M: Reprogramming of circulatory cells in sepsis and SIRS. J Endotoxin Res 11(5):311-320, 2005. (Pubitemid 41556040)
3. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC: Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167(15):1655-1663, 2007. (Pubitemid 47280347)
4. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schüttler J: Coincidence of pro-and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 30(5):1015-1023, 2002. (Pubitemid 34508022)
5. Monneret G, Venet F, Pachot A, Lepape A: Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 14(1-2):64-78, 2008. (Pubitemid 351356886)
6. Monneret G, Finck M-E, Venet F, Debard A-L, Bohé J, Bienvenu J, Lepape A: The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95(2):193-198, 2004. (Pubitemid 39237665)
7. Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CG, Tervaert JW: Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 26(7):883-892, 2000. (Pubitemid 30616041)
8. Aalto H, Takala A, Kautiainen H, Siitonen S, Repo H: Monocyte CD14 and soluble CD14 in predicting mortality of patients with severe community acquired infection. Scand J Infect Dis 39(6-7):596-603, 2007. (Pubitemid 47009171)
9. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard A-L, Thizy H, Bienvenu J, Gueyffier F, Vanhems P: Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32(8):1175-1183, 2006. (Pubitemid 44232412)
10. Stephan RN, Ayala A, Harkema JM, Dean RE, Border JR, Chaudry IH: Mechanism of immunosuppression following hemorrhage: defective antigen presentation by macrophages. J Surg Res 46(6):553-556, 1989. (Pubitemid 19170320)
11. Chaudry IH, Ayala A, Ertel W, Stephan RN: Hemorrhage and resuscitation: immunological aspects. Am J Physiol 259(4 Pt 2):R663-R678, 1990. (Pubitemid 20352337)
12. Stephan RN, Kupper TS, Geha AS, Baue AE, Chaudry IH: Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 122(1):62-68, 1987. (Pubitemid 17229259)
13. Livingston DH, Malangoni MA: An experimental study of susceptibility to infection after hemorrhagic shock. Surg Gynecol Obstet 168(2):138-142, 1989. (Pubitemid 19074453)
14. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA: The sepsis seesaw: tilting toward immunosuppression. Nat Med 15(5):496-497, 2009.
15. Haveman JW, Van den Berg AP, van den Berk JM, Mesander G, Slooff MJ, de Leij LH, The TH: Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake. Transpl Infect Dis 1(3):146-152, 1999.
16. Kinasewitz G, Yan SB, Basson B, Comp P, Russell J, Cariou A, Um S, Utterback B, Laterre P-F, Dhainaut J-F, for the PROWESS Sepsis Study Group: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care 8(2):R82-R90, 2004.
17. Pierrakos C, Vincent J-L: Sepsis biomarkers: a review. Crit Care 14(1):R15, 2010.
18. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336(4):243-250, 1997. (Pubitemid 27044625)
19. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S: New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 29(4):880-886, 2001. (Pubitemid 32299732)
20. Angus DC, Carlet J: Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med 29(3):368-377, 2003. (Pubitemid 36379436)
21. Schaaf B, Luitjens K, Goldmann T, van Bremen T, Sayk F, Dodt C, Dalhoff K, Droemann D: Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes. Diagn Pathol 4(1):12, 2009.
22. Döcke W-D, Höflich C, Davis KA, Röttgers K, Meisel C, Kiefer P, Weber SU, Hedwig-Geissing M, Kreuzfelder E, Tschentscher P, et al.: Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 51(12): 2341-2347, 2005. (Pubitemid 41692579)
23. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on Bsepsis-related problems[ of the European Society of Intensive Care Medicine. Crit Care Med 26(11): 1793-1800, 1998. (Pubitemid 28527688)
24. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 286(14): 1754-1758, 2001. (Pubitemid 33010262)
25. Chiche L, Forel J-M, Roch A, Guervilly C, Pauly V, Allardet-Servent J, Gainnier M, Zandotti C, Papazian L: Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 37(6):1850-1857, 2009.
26. Beck GC, Brinkkoetter P, Hanusch C, Schulte J, van Ackern K, van der Woude FJ, Yard BA: Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 8(6):485-491, 2004. (Pubitemid 40073684)
27. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 11(1):161-167, 2004. (Pubitemid 38090671)
28. Cabioglu N, Bilgic S, Deniz G, Aktas E, Seyhun Y, Turna A, Gunay K, Esen F: Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg 137(9):1037-1043, discussion 1043, 2002.
29. Gaviria JM, Dale DC, Root RK: Neutrophils: function and role in sepsis syndrome. Sepsis 2(2):107-117, 1998. (Pubitemid 128511706)
30. Wesche DE, Lomas-Neira JL, Perl M, Chung C-S, Ayala A: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 78(2):325-337, 2005. (Pubitemid 41061305)
31. Barton BE: The biological effects of interleukin 6. Med Res Rev 16(1):87-109, 1996. (Pubitemid 26034189)
32. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al.: HIF-1alpha is essential for myeloid cellYmediated inflammation. Cell 112(5):645-657, 2003. (Pubitemid 36331777)
33. Bosco MC, Puppo M, Santangelo C, Anfosso L, Pfeffer U, Fardin P, Battaglia F, Varesio L: Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CCchemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 177(3): 1941-1955, 2006. (Pubitemid 44092535)
34. Ertel W, Morrison MH, Ayala A, Chaudry IH: Chloroquine attenuates hemorrhagic shockYinduced immunosuppression and decreases susceptibility to sepsis. Arch Surg 127(1):70-76, 1992.
35. Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH: Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 157(12):5748-5754, 1996 (Pubitemid 126449000)